ES2060150T3 - Nuevos derivados de leucotrieno-b4, procedimiento para su preparacion y su utilizacion como medicamentos. - Google Patents

Nuevos derivados de leucotrieno-b4, procedimiento para su preparacion y su utilizacion como medicamentos.

Info

Publication number
ES2060150T3
ES2060150T3 ES90904594T ES90904594T ES2060150T3 ES 2060150 T3 ES2060150 T3 ES 2060150T3 ES 90904594 T ES90904594 T ES 90904594T ES 90904594 T ES90904594 T ES 90904594T ES 2060150 T3 ES2060150 T3 ES 2060150T3
Authority
ES
Spain
Prior art keywords
group
atoms
radical
pct
trans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90904594T
Other languages
English (en)
Inventor
Bernd Buchmann
Werner Skuballa
Joseph Heindl
Wolfgang Frohlich
Roland Ekerdt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2060150T3 publication Critical patent/ES2060150T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
    • C07C33/30—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL INVENTO CONCIERNE A NUEVOS LEUCOTRIENOS B4 ANALOGOS A LA FORMULA (I) (FORMULA), EN LA QUE R1 SIMBOLIZA LOS RESTOS CH2OH, CH3, CF3, COOR4 O EL RESTO CONHR5; A UN TRANS-TRANS-CH=CH-CH=CH-, TRANS-CH2-CH2-CH=CH RUPO ALQUILENO LINEAL O RAMIFICADO, SATURADO O INSATURADO, DE HASTA 10 ATOMOS DE C; D UNA UNION DIRECTA, OXIGENO, AZUFRE, UN GRUPO -C(TRIPLE ENLACE)CTOS UNA UNION DIRECTA; R2 UN H O UN RESTO ACIDO DE UN ACIDO ORGANICO DE 1-15 ATOMOS DE C Y R3 UN H, UN RESTO ALQUILO CON 1-10 ATOMOS DE C EVENTUALMENTE SUSTITUIDO, UN RESTO CICLOALQUILO CON 3-10 ATOMOS DE C, UN RESTO ARILO EVENTUALMENTE SUSTITUIDO CON 6-10 ATOMOS DE C O UN RESTO HETEROCICLICO DE 5-6 ESLABONES Y, EN CASO DE QUE R4 SIGNIFIQUE H, SUS SALES CON BASES FISIOLOGICAMENTE TOLERABLES Y SUS CICLODEXTRINCLATRATOS. PROCEDIMIENTO PARA SU PRODUCCION Y SU APLICACION FARMACOLOGICA.
ES90904594T 1989-03-17 1990-03-16 Nuevos derivados de leucotrieno-b4, procedimiento para su preparacion y su utilizacion como medicamentos. Expired - Lifetime ES2060150T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3909327A DE3909327A1 (de) 1989-03-17 1989-03-17 Neue leukotrien-b4-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2060150T3 true ES2060150T3 (es) 1994-11-16

Family

ID=6376896

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90904594T Expired - Lifetime ES2060150T3 (es) 1989-03-17 1990-03-16 Nuevos derivados de leucotrieno-b4, procedimiento para su preparacion y su utilizacion como medicamentos.

Country Status (8)

Country Link
US (1) US5196570A (es)
EP (1) EP0419610B1 (es)
JP (1) JPH03505221A (es)
AT (1) ATE94532T1 (es)
DE (2) DE3909327A1 (es)
DK (1) DK0419610T3 (es)
ES (1) ES2060150T3 (es)
WO (1) WO1990011271A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1228030B1 (en) * 1999-11-09 2005-06-01 Alcon Inc. Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
US8287529B2 (en) 2008-09-05 2012-10-16 Tyco Healthcare Group Lp Electrosurgical apparatus with high speed energy recovery
US8287527B2 (en) 2008-09-30 2012-10-16 Vivant Medical, Inc. Microwave system calibration apparatus and method of use
US8152802B2 (en) 2009-01-12 2012-04-10 Tyco Healthcare Group Lp Energy delivery algorithm filter pre-loading

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109225B1 (en) * 1982-11-11 1985-08-28 Beecham Group Plc Arachidonic acid analogues, processes for their preparation and their use in medicine
ES2052639T3 (es) * 1987-06-26 1994-07-16 Searle & Co Analogos de fenilen-, furil- y tienil-leucotrieno b4.
US4855324A (en) * 1987-12-08 1989-08-08 G. D. Searle & Co. Furyl, phenylene, and thienyl leukotriene B4 analogues

Also Published As

Publication number Publication date
DK0419610T3 (da) 1993-12-20
JPH03505221A (ja) 1991-11-14
EP0419610B1 (de) 1993-09-15
DE59002723D1 (de) 1993-10-21
EP0419610A1 (de) 1991-04-03
US5196570A (en) 1993-03-23
DE3909327A1 (de) 1990-09-20
ATE94532T1 (de) 1993-10-15
WO1990011271A1 (de) 1990-10-04

Similar Documents

Publication Publication Date Title
DK132789A (da) 9-halogen-(z)-prostaglandinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ES539658A0 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
ES545817A0 (es) Un metodo para preparar derivados de piperazina
NL300396I1 (nl) Nieuwe derivaten met naftalinestructuren, werkwijze voor de bereiding ervan en de farmaceutische preparaten die deze bevatten
ES8900229A1 (es) Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
PT77110A (fr) Procede de preparation de nouveaux derives de la xanthine
ZA907876B (en) 24-homo vitamin d derivatives,process for their production and pharmaceutical preparations obtained therefrom
NO910304L (no) Nye leukotrien-b4-derivater, fremgangsmaate for deres fremstilling og deres anvendelse som legemiddel.
ES2060150T3 (es) Nuevos derivados de leucotrieno-b4, procedimiento para su preparacion y su utilizacion como medicamentos.
HUT58306A (en) Process for producing new, 2-substituted 4-(3-alkyl-5-terc-butyl-4-hydroxy-phenyl)-thiazols and pharmaceutical compositions containing them as active components
SE8300855D0 (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
FI853233A0 (fi) 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
KR870005985A (ko) 구아니디노벤조 에스테르유도체 및 그의 제조방법
HU9202260D0 (en) 9-halogene-11beta-hydroxi-prostaglandine derivatives method for producing them and their utilization as medicament
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
SE7904543L (sv) Nya joniska bensen-polyjodidderivat for anvendning som kontrastmedel vid rontgenbehandling
ZA84261B (en) Bicyclo(4.2.0)1,3,5-octatriene derivatives,a process for their preparation and pharmaceutical compositions containing them
SE7506803L (sv) Hexahydro-diazepino-indolderivat och forfarande for framstellning derav
ATE92031T1 (de) Neue leukotrien-b 4 -derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE11912T1 (de) ((indol-3-yl)-3-amino-2-propionyloxy)-2essigs|urederivate, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
DE2964850D1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE6063T1 (de) Cycloalkano-thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 419610

Country of ref document: ES